A Phase 1b/2 study evaluating the safety and efficacy of MPDL3280A in combination with either OBINUTUZUMAB plus BENDAMUSTINE or OBINUTUZUMAB plus chop in patients with follicular lymphoma or diffuse large b-cell lymphoma
- Gilbertson, Michael (Primary Chief Investigator (PCI))
Project: Research